|  | 

News and Headlines

Cardinal Health's dismal forecast drags rivals, drugmakers down

img-responsive

Cardinal Health's dismal forecast drags rivals, drugmakers downCardinal Health Inc forecast fiscal year 2018 profit well below analyst estimates, highlighting the drag on drug distributors and generic drugmakers due to stubbornly low generic drug prices. The company’s shares slumped as much as 9.8 percent, while rivals McKesson Corp were down nearly 3 percent and AmerisourceBergen Corp 4 percent. Generic drugmakers Teva Pharmaceutical Industries Ltd and Mylan NV were also lower on Wednesday.


cardinal-health39s-dismal-forecast-drags-rivals-drugmakers-down

ABOUT THE AUTHOR

POST YOUR COMMENTS

Your email address will not be published. Required fields are marked *

Name *

Email *

Website